Explore
Trendline
Travere Therapeutics Grants Inducement Equity to New Employees Under Nasdaq Rule
Travere Therapeutics Grants Inducement Equity to New Employees Under Nasdaq Rule
Read More
Trendline
Alpha Cognition Announces Inducement Grants Under Nasdaq Rule
Alpha Cognition Announces Inducement Grants Under Nasdaq Rule
Read More
Trendline
Integrant Secures Nasdaq Ticker 'INGT' for Upcoming IPO, Aiming to Revolutionize Regenerative Medicine
Integrant Secures Nasdaq Ticker 'INGT' for Upcoming IPO, Aiming to Revolutionize Regenerative Medicine
Read More
Trendline
QVC Group to File for Chapter 11 Bankruptcy Amid $5 Billion Debt Restructuring
QVC Group to File for Chapter 11 Bankruptcy Amid $5 Billion Debt Restructuring
Read More
Trendline
Wall Street Reaches New Heights as U.S. Stocks Climb Amid Strong Corporate Earnings
Wall Street Reaches New Heights as U.S. Stocks Climb Amid Strong Corporate Earnings
Read More
Reuters
Trading Day: S&P 500, Nasdaq nab all-time closing highs, buoyed by Middle East optimism
By Stephen Culp NEW YORK, April 15 (Reuters) - The S&P 500 and the Nasdaq both logged record closing highs on Wednesday as investors assessed developments in the U.S.-Iran conflict and turned their focus to corporate earnings.
Read More
AP News
Wall Street sets another record after US stocks tick higher
The U.S. stock market ticked upward to another record high
Read More
Trendline
Triller Reveals Zero Revenue from Media Businesses, Faces Uncertain Future
Triller Reveals Zero Revenue from Media Businesses, Faces Uncertain Future
Read More
Trendline
Veracyte to Announce Q1 2026 Financial Results, Impacting Cancer Diagnostics Sector
Veracyte to Announce Q1 2026 Financial Results, Impacting Cancer Diagnostics Sector
Read More
Trendline
Travere Therapeutics Grants Inducement RSUs to New Employees Under Nasdaq Rule
Travere Therapeutics Grants Inducement RSUs to New Employees Under Nasdaq Rule
Read More
Trendline
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations, Enhancing U.S. Presence
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations, Enhancing U.S. Presence
Read More
Trendline
Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq
Biotech Companies Alamar, Hemab, Kailera, and Seaport Advance IPO Plans on Nasdaq
Read More